M. Veltkamp, M. Drent, and R. P. Baughman, “Infliximab or biosimilars in sarcoidosis; to switch or not to switch?”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 32, no. 4, pp. 280–283, Jan. 2016, Accessed: Aug. 21, 2025. [Online]. Available: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/5001